Hikma receives FDA approval and launches the generic version of Victoza, Liraglutide, in the US
Phase 2 Clinical Trial Results The pivotal Phase 2 trial (Jastreboff et al., 2023, PMID: 37351564) published in *The New England Journal of Medicine* enrolled 338 adults with obesity
Consistency of care: When a medication is covered by your insurance, youre less likely to experience gaps in access that can disrupt your health progress
Diabetes 64 , 23982408 (2015)
Clinical trial participation, identified via the NIHR 'Be Part of Research' portal, ClinicalTrials.gov, or the ISRCTN registry, is the only currently regulated access route in the UK